Cancer Treatment and Research Communications impact factor overview
Automatically generated from the journal record shown on this page.
Impact factor overview
Cancer Treatment and Research Communications is listed in this directory with bibliometric information for 2025. It is published by ELSEVIER. The recorded Journal Impact Factor is 2.400. Its listed JIF quartile is Q3.
Ranking and quartile
The recorded JIF rank is 200 out of 326 journals in its listed category. A Q3 designation describes the journal’s position within its subject category; it should not be used as a direct measure of the quality of an individual article.
Citation profile
The record contains 1,716 total citations, 71 total articles, 79 citable items. The five-year JIF is 0.000, which is 2.400 points below the listed two-year JIF. These values use different citation windows and should be interpreted together rather than as a direct trend. The JIF without journal self-citations is recorded as 2.300. The Journal Citation Indicator is listed as 0.520.
Citation half-life
The cited half-life is recorded as 3.3 years, describing the median age of articles cited in the reporting year. The citing half-life is 6.5 years, reflecting the median age of references used by the journal’s articles.
Journal identifiers and verification
Cancer Treatment and Research Communications is identified in this record by print ISSN 2468-2942 and electronic ISSN 2468-2942. Use the ISSN when checking library catalogues, publisher records, indexing databases, or the official Journal Citation Reports entry.
Complete journal information
All values below come directly from the database record.
| Journal name | Cancer Treatment and Research Communications |
|---|---|
| Abbreviated journal | CANCER TREAT RES COM |
| Publisher | ELSEVIER |
| Metric year | 2025 |
| Overall rank | 6,685 |
| ISSN | 2468-2942 |
| eISSN | 2468-2942 |
| Total cites | 1,716 |
| Total articles | 71 |
| Citable items | 79 |
| Cited half-life | 3.3 years |
| Citing half-life | 6.5 years |
| Impact Factor | 2.400 |
| 5-Year JIF | 0.000 |
| JIF without self-cites | 2.300 |
| Journal Citation Indicator | 0.520 |
| JIF quartile | Q3 |
| JIF rank | 200/326 |
| Record last updated |
Frequently asked questions
What is the 2025 impact factor of Cancer Treatment and Research Communications?
The impact factor recorded in this directory for Cancer Treatment and Research Communications is 2.400 for the 2025 metric year.
What quartile is Cancer Treatment and Research Communications?
Cancer Treatment and Research Communications is listed in quartile Q3. Quartiles describe a journal’s position within a subject category and should be interpreted within that field.
Who publishes Cancer Treatment and Research Communications?
Cancer Treatment and Research Communications is listed as being published by ELSEVIER.
Can a journal impact factor be used to judge an individual article?
No. A journal impact factor is a journal-level citation average. It does not measure the quality, reliability or influence of every individual article published by that journal.
Related journal profiles
Additional records from the same publisher or with a similar listed impact factor.